units

PAC4462

Faculty of Pharmacy and Pharmaceutical Sciences

18 September 2017 22 November 2024
Monash University

Undergraduate - Unit

This unit entry is for students who completed this unit in 2013 only. For students planning to study the unit, please refer to the unit indexes in the the current edition of the Handbook. If you have any queries contact the managing faculty for your course or area of study.

print version

6 points, SCA Band 2, 0.125 EFTSL

To find units available for enrolment in the current year, you must make sure you use the indexes and browse unit tool in the current edition of the Handbook.

LevelUndergraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedSunway Second semester 2013 (Day)
Parkville Second semester 2013 (Day)
Coordinator(s)Professor Colin Pouton (Parkville); Ms Yelly Oktavia Sari (Sunway)

Synopsis

This unit aims to lay a foundation of knowledge about diseases and disorders in neurology and oncology and to provide the relationship between pathophysiology and the rational design and use of drugs in the management of conditions of this type.

The chemistry, pharmacology and clinical aspects of medications associated with each area are presented in detail in an integrated fashion.

Drug therapy principles for particular conditions and patient groups will be emphasised enabling students to acquire the skills necessary to provide clinical pharmacy services within these areas.

Specifically the unit will cover epilepsy, migraine, multiple sclerosis, Parkinson's disease, stroke and a range of common malignancies such as breast cancer, prostate cancer, bowel cancer, skin cancer, leukaemia, lung cancer, etc.

It will also deal with principles of palliative care and management of patients at the end of life.

Students will perform a number of tasks which will help with the development of critical thinking skills and oral and/or written communication skills.

Outcomes

  1. This unit aims to lay a foundation of knowledge about diseases and disorders in neurology and oncology and to provide the relationship between pathophysiology and the rational design and use of drugs in the management of conditions of this type.
  2. The chemistry, pharmacology and clinical aspects of medications associated with each area are presented in detail in an integrated fashion.
  3. Drug therapy principles for particular conditions and patient groups will be emphasised enabling students to acquire the skills necessary to provide clinical pharmacy services within these areas.
  4. Specifically the unit will cover epilepsy, migraine, multiple sclerosis, Parkinson's disease, stroke and a range of common malignancies such as breast cancer, prostate cancer, bowel cancer, skin cancer, leukaemia, lung cancer, etc. It will also deal with principles of palliative care and management of patients at the end of life.
  5. Students will perform a number of tasks which will help with the development of critical thinking skills and oral and written communication skills.

Assessment

Final exam (3 hour): 70%; in-semester MCQ or short answer tests: 20%; practical assessments (case-based exercises): 10%.

Chief examiner(s)

Professor Colin Pouton

Contact hours

Contact hours for on-campus students:
Thirty six 1-hour lectures or equivalent, delivered face to face or online
Six hours of tutorials (Two 3-hour sessions or shorter online sessions)

Prerequisites

PAC4451

Additional information on this unit is available from the faculty at:

http://www.monash.edu/pharm/current/